nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolterodine—CYP2C19—Sorafenib—liver cancer	0.162	0.261	CbGbCtD
Tolterodine—CYP2C9—Sorafenib—liver cancer	0.135	0.217	CbGbCtD
Tolterodine—CYP2D6—Sorafenib—liver cancer	0.123	0.199	CbGbCtD
Tolterodine—CYP3A4—Sorafenib—liver cancer	0.0783	0.126	CbGbCtD
Tolterodine—CYP2D6—Doxorubicin—liver cancer	0.0747	0.12	CbGbCtD
Tolterodine—CYP3A4—Doxorubicin—liver cancer	0.0475	0.0766	CbGbCtD
Tolterodine—Gastrooesophageal reflux disease—Sorafenib—liver cancer	0.00551	0.0531	CcSEcCtD
Tolterodine—Influenza like illness—Sorafenib—liver cancer	0.00483	0.0466	CcSEcCtD
Tolterodine—Dry skin—Sorafenib—liver cancer	0.00331	0.0319	CcSEcCtD
Tolterodine—Flushing—Sorafenib—liver cancer	0.00232	0.0224	CcSEcCtD
Tolterodine—Angioedema—Sorafenib—liver cancer	0.00199	0.0192	CcSEcCtD
Tolterodine—Arthralgia—Sorafenib—liver cancer	0.00185	0.0179	CcSEcCtD
Tolterodine—Dry mouth—Sorafenib—liver cancer	0.00181	0.0175	CcSEcCtD
Tolterodine—Influenza like illness—Epirubicin—liver cancer	0.00179	0.0172	CcSEcCtD
Tolterodine—Anaphylactic shock—Sorafenib—liver cancer	0.00178	0.0171	CcSEcCtD
Tolterodine—Infection—Sorafenib—liver cancer	0.00176	0.017	CcSEcCtD
Tolterodine—Dry eye—Epirubicin—liver cancer	0.0017	0.0164	CcSEcCtD
Tolterodine—Influenza like illness—Doxorubicin—liver cancer	0.00165	0.0159	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Sorafenib—liver cancer	0.00162	0.0156	CcSEcCtD
Tolterodine—Abnormal vision—Epirubicin—liver cancer	0.0016	0.0155	CcSEcCtD
Tolterodine—Dry eye—Doxorubicin—liver cancer	0.00157	0.0152	CcSEcCtD
Tolterodine—Dyspepsia—Sorafenib—liver cancer	0.00156	0.0151	CcSEcCtD
Tolterodine—Fatigue—Sorafenib—liver cancer	0.00153	0.0148	CcSEcCtD
Tolterodine—Pain—Sorafenib—liver cancer	0.00152	0.0146	CcSEcCtD
Tolterodine—Constipation—Sorafenib—liver cancer	0.00152	0.0146	CcSEcCtD
Tolterodine—Abnormal vision—Doxorubicin—liver cancer	0.00148	0.0143	CcSEcCtD
Tolterodine—Gastrointestinal pain—Sorafenib—liver cancer	0.00145	0.014	CcSEcCtD
Tolterodine—Abdominal pain—Sorafenib—liver cancer	0.0014	0.0135	CcSEcCtD
Tolterodine—Anaphylactoid reaction—Epirubicin—liver cancer	0.00138	0.0133	CcSEcCtD
Tolterodine—Hypersensitivity—Sorafenib—liver cancer	0.00131	0.0126	CcSEcCtD
Tolterodine—Anaphylactoid reaction—Doxorubicin—liver cancer	0.00128	0.0123	CcSEcCtD
Tolterodine—Asthenia—Sorafenib—liver cancer	0.00127	0.0123	CcSEcCtD
Tolterodine—Dry skin—Epirubicin—liver cancer	0.00122	0.0118	CcSEcCtD
Tolterodine—Diarrhoea—Sorafenib—liver cancer	0.00122	0.0117	CcSEcCtD
Tolterodine—Dizziness—Sorafenib—liver cancer	0.00117	0.0113	CcSEcCtD
Tolterodine—Dry skin—Doxorubicin—liver cancer	0.00113	0.0109	CcSEcCtD
Tolterodine—Headache—Sorafenib—liver cancer	0.00111	0.0107	CcSEcCtD
Tolterodine—Bronchitis—Epirubicin—liver cancer	0.00111	0.0107	CcSEcCtD
Tolterodine—Dysuria—Epirubicin—liver cancer	0.00108	0.0104	CcSEcCtD
Tolterodine—Upper respiratory tract infection—Epirubicin—liver cancer	0.00107	0.0103	CcSEcCtD
Tolterodine—Weight increased—Epirubicin—liver cancer	0.00105	0.0101	CcSEcCtD
Tolterodine—Bronchitis—Doxorubicin—liver cancer	0.00103	0.0099	CcSEcCtD
Tolterodine—Urinary tract infection—Epirubicin—liver cancer	0.001	0.00964	CcSEcCtD
Tolterodine—Dysuria—Doxorubicin—liver cancer	0.000999	0.00963	CcSEcCtD
Tolterodine—Upper respiratory tract infection—Doxorubicin—liver cancer	0.000993	0.00957	CcSEcCtD
Tolterodine—Weight increased—Doxorubicin—liver cancer	0.000972	0.00937	CcSEcCtD
Tolterodine—Sinusitis—Epirubicin—liver cancer	0.000966	0.00931	CcSEcCtD
Tolterodine—Urinary tract infection—Doxorubicin—liver cancer	0.000926	0.00892	CcSEcCtD
Tolterodine—Oedema peripheral—Epirubicin—liver cancer	0.00091	0.00877	CcSEcCtD
Tolterodine—Sinusitis—Doxorubicin—liver cancer	0.000893	0.00861	CcSEcCtD
Tolterodine—Visual impairment—Epirubicin—liver cancer	0.00089	0.00858	CcSEcCtD
Tolterodine—Flushing—Epirubicin—liver cancer	0.000857	0.00827	CcSEcCtD
Tolterodine—Oedema peripheral—Doxorubicin—liver cancer	0.000842	0.00812	CcSEcCtD
Tolterodine—Visual impairment—Doxorubicin—liver cancer	0.000824	0.00794	CcSEcCtD
Tolterodine—Flushing—Doxorubicin—liver cancer	0.000793	0.00765	CcSEcCtD
Tolterodine—Flatulence—Epirubicin—liver cancer	0.000792	0.00764	CcSEcCtD
Tolterodine—Flatulence—Doxorubicin—liver cancer	0.000733	0.00707	CcSEcCtD
Tolterodine—Vertigo—Epirubicin—liver cancer	0.000723	0.00697	CcSEcCtD
Tolterodine—Palpitations—Epirubicin—liver cancer	0.000711	0.00685	CcSEcCtD
Tolterodine—Chest pain—Epirubicin—liver cancer	0.000685	0.0066	CcSEcCtD
Tolterodine—Arthralgia—Epirubicin—liver cancer	0.000685	0.0066	CcSEcCtD
Tolterodine—Anxiety—Epirubicin—liver cancer	0.000682	0.00658	CcSEcCtD
Tolterodine—Dry mouth—Epirubicin—liver cancer	0.00067	0.00646	CcSEcCtD
Tolterodine—Vertigo—Doxorubicin—liver cancer	0.000669	0.00644	CcSEcCtD
Tolterodine—Confusional state—Epirubicin—liver cancer	0.000662	0.00638	CcSEcCtD
Tolterodine—Palpitations—Doxorubicin—liver cancer	0.000658	0.00634	CcSEcCtD
Tolterodine—Anaphylactic shock—Epirubicin—liver cancer	0.000656	0.00633	CcSEcCtD
Tolterodine—Oedema—Epirubicin—liver cancer	0.000656	0.00633	CcSEcCtD
Tolterodine—Infection—Epirubicin—liver cancer	0.000652	0.00629	CcSEcCtD
Tolterodine—Tachycardia—Epirubicin—liver cancer	0.000641	0.00618	CcSEcCtD
Tolterodine—Chest pain—Doxorubicin—liver cancer	0.000634	0.00611	CcSEcCtD
Tolterodine—Arthralgia—Doxorubicin—liver cancer	0.000634	0.00611	CcSEcCtD
Tolterodine—Anxiety—Doxorubicin—liver cancer	0.000631	0.00609	CcSEcCtD
Tolterodine—Dry mouth—Doxorubicin—liver cancer	0.00062	0.00597	CcSEcCtD
Tolterodine—Confusional state—Doxorubicin—liver cancer	0.000612	0.0059	CcSEcCtD
Tolterodine—Anaphylactic shock—Doxorubicin—liver cancer	0.000607	0.00585	CcSEcCtD
Tolterodine—Oedema—Doxorubicin—liver cancer	0.000607	0.00585	CcSEcCtD
Tolterodine—Infection—Doxorubicin—liver cancer	0.000603	0.00582	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000598	0.00576	CcSEcCtD
Tolterodine—Tachycardia—Doxorubicin—liver cancer	0.000593	0.00571	CcSEcCtD
Tolterodine—Somnolence—Epirubicin—liver cancer	0.000584	0.00563	CcSEcCtD
Tolterodine—Dyspepsia—Epirubicin—liver cancer	0.000578	0.00557	CcSEcCtD
Tolterodine—Fatigue—Epirubicin—liver cancer	0.000566	0.00546	CcSEcCtD
Tolterodine—Pain—Epirubicin—liver cancer	0.000561	0.00541	CcSEcCtD
Tolterodine—Constipation—Epirubicin—liver cancer	0.000561	0.00541	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000553	0.00533	CcSEcCtD
Tolterodine—Feeling abnormal—Epirubicin—liver cancer	0.000541	0.00521	CcSEcCtD
Tolterodine—Somnolence—Doxorubicin—liver cancer	0.00054	0.0052	CcSEcCtD
Tolterodine—Gastrointestinal pain—Epirubicin—liver cancer	0.000537	0.00517	CcSEcCtD
Tolterodine—Dyspepsia—Doxorubicin—liver cancer	0.000535	0.00515	CcSEcCtD
Tolterodine—Fatigue—Doxorubicin—liver cancer	0.000524	0.00505	CcSEcCtD
Tolterodine—Constipation—Doxorubicin—liver cancer	0.000519	0.00501	CcSEcCtD
Tolterodine—Pain—Doxorubicin—liver cancer	0.000519	0.00501	CcSEcCtD
Tolterodine—Abdominal pain—Epirubicin—liver cancer	0.000519	0.005	CcSEcCtD
Tolterodine—Feeling abnormal—Doxorubicin—liver cancer	0.0005	0.00482	CcSEcCtD
Tolterodine—Gastrointestinal pain—Doxorubicin—liver cancer	0.000497	0.00479	CcSEcCtD
Tolterodine—Hypersensitivity—Epirubicin—liver cancer	0.000484	0.00466	CcSEcCtD
Tolterodine—Abdominal pain—Doxorubicin—liver cancer	0.00048	0.00463	CcSEcCtD
Tolterodine—Asthenia—Epirubicin—liver cancer	0.000471	0.00454	CcSEcCtD
Tolterodine—Diarrhoea—Epirubicin—liver cancer	0.000449	0.00433	CcSEcCtD
Tolterodine—Hypersensitivity—Doxorubicin—liver cancer	0.000447	0.00431	CcSEcCtD
Tolterodine—Asthenia—Doxorubicin—liver cancer	0.000436	0.0042	CcSEcCtD
Tolterodine—Dizziness—Epirubicin—liver cancer	0.000434	0.00418	CcSEcCtD
Tolterodine—Diarrhoea—Doxorubicin—liver cancer	0.000416	0.00401	CcSEcCtD
Tolterodine—Headache—Epirubicin—liver cancer	0.000411	0.00396	CcSEcCtD
Tolterodine—Dizziness—Doxorubicin—liver cancer	0.000402	0.00387	CcSEcCtD
Tolterodine—Headache—Doxorubicin—liver cancer	0.00038	0.00367	CcSEcCtD
Tolterodine—Brompheniramine—CYP2E1—liver cancer	0.000219	0.425	CrCbGaD
Tolterodine—Phenprocoumon—ALB—liver cancer	0.000159	0.308	CrCbGaD
Tolterodine—Orphenadrine—CYP2E1—liver cancer	0.000138	0.268	CrCbGaD
Tolterodine—CHRM3—Metabolism—PIK3CG—liver cancer	5.09e-05	0.000185	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—IL2—liver cancer	5.09e-05	0.000185	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—IL2—liver cancer	5.07e-05	0.000184	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—TERT—liver cancer	5.07e-05	0.000184	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—CYCS—liver cancer	5.06e-05	0.000184	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—TERT—liver cancer	5.05e-05	0.000183	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—IL2—liver cancer	5.02e-05	0.000182	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—CYCS—liver cancer	5.02e-05	0.000182	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—PIK3CA—liver cancer	5.01e-05	0.000182	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—TERT—liver cancer	5e-05	0.000182	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—RAF1—liver cancer	4.97e-05	0.00018	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—GGT1—liver cancer	4.97e-05	0.00018	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—GOT1—liver cancer	4.97e-05	0.00018	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—CRABP1—liver cancer	4.96e-05	0.00018	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—GOT1—liver cancer	4.92e-05	0.000179	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—GGT1—liver cancer	4.92e-05	0.000179	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—PPARG—liver cancer	4.91e-05	0.000178	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—PIK3CB—liver cancer	4.85e-05	0.000176	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—MTOR—liver cancer	4.85e-05	0.000176	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—GSTP1—liver cancer	4.85e-05	0.000176	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—PIK3CA—liver cancer	4.79e-05	0.000174	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—HMOX1—liver cancer	4.78e-05	0.000174	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—RAF1—liver cancer	4.76e-05	0.000173	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—PIK3CB—liver cancer	4.65e-05	0.000169	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—MTOR—liver cancer	4.65e-05	0.000169	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—KDR—liver cancer	4.63e-05	0.000168	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—HRAS—liver cancer	4.63e-05	0.000168	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—KDR—liver cancer	4.62e-05	0.000168	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—MAPK14—liver cancer	4.6e-05	0.000167	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—MAPK14—liver cancer	4.59e-05	0.000167	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—KDR—liver cancer	4.58e-05	0.000166	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—CDKN1B—liver cancer	4.55e-05	0.000165	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—MAPK14—liver cancer	4.55e-05	0.000165	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—ESR1—liver cancer	4.52e-05	0.000164	CbGpPWpGaD
Tolterodine—CHRM4—GPCR downstream signaling—AKT1—liver cancer	4.5e-05	0.000163	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—ESR1—liver cancer	4.5e-05	0.000163	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—PIK3CD—liver cancer	4.47e-05	0.000162	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—CASP3—liver cancer	4.46e-05	0.000162	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—F2—liver cancer	4.46e-05	0.000162	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—GSTP1—liver cancer	4.46e-05	0.000162	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—ESR1—liver cancer	4.46e-05	0.000162	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—GSTM1—liver cancer	4.46e-05	0.000162	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—IL2—liver cancer	4.46e-05	0.000162	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—F2—liver cancer	4.45e-05	0.000161	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—HRAS—liver cancer	4.44e-05	0.000161	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—IL6—liver cancer	4.43e-05	0.000161	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—GSTP1—liver cancer	4.42e-05	0.00016	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—ALB—liver cancer	4.42e-05	0.00016	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—F2—liver cancer	4.4e-05	0.00016	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—HMOX1—liver cancer	4.4e-05	0.00016	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—HMOX1—liver cancer	4.36e-05	0.000158	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—CDKN1B—liver cancer	4.36e-05	0.000158	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—CCND1—liver cancer	4.34e-05	0.000158	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—HPGDS—liver cancer	4.34e-05	0.000157	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—JUN—liver cancer	4.33e-05	0.000157	CbGpPWpGaD
Tolterodine—CHRM5—GPCR downstream signaling—AKT1—liver cancer	4.31e-05	0.000157	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—CTNNB1—liver cancer	4.3e-05	0.000156	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—CASP3—liver cancer	4.27e-05	0.000155	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—APC—liver cancer	4.27e-05	0.000155	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—PIK3CG—liver cancer	4.27e-05	0.000155	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—IL2—liver cancer	4.27e-05	0.000155	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—APC—liver cancer	4.26e-05	0.000154	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—PIK3CG—liver cancer	4.26e-05	0.000154	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—IL6—liver cancer	4.25e-05	0.000154	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—CYP1A1—liver cancer	4.22e-05	0.000153	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—MMP9—liver cancer	4.22e-05	0.000153	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—APC—liver cancer	4.21e-05	0.000153	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—PIK3CG—liver cancer	4.21e-05	0.000153	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—CDKN1A—liver cancer	4.2e-05	0.000152	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—CCND1—liver cancer	4.16e-05	0.000151	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—JUN—liver cancer	4.15e-05	0.000151	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—CTNNB1—liver cancer	4.12e-05	0.000149	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—MAPK8—liver cancer	4.1e-05	0.000149	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—GSTM1—liver cancer	4.1e-05	0.000149	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—AKT1—liver cancer	4.09e-05	0.000148	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—GSTM1—liver cancer	4.06e-05	0.000147	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—MMP9—liver cancer	4.04e-05	0.000147	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—CDKN1A—liver cancer	4.02e-05	0.000146	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—BRAF—liver cancer	4.01e-05	0.000146	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—BRAF—liver cancer	4e-05	0.000145	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—BRAF—liver cancer	3.96e-05	0.000144	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—MTHFR—liver cancer	3.94e-05	0.000143	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—MAPK8—liver cancer	3.93e-05	0.000143	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—AKT1—liver cancer	3.92e-05	0.000142	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—PIK3CB—liver cancer	3.9e-05	0.000142	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—CYP1A1—liver cancer	3.89e-05	0.000141	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—PSMD10—liver cancer	3.87e-05	0.00014	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—PSMA4—liver cancer	3.87e-05	0.00014	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—PPARA—liver cancer	3.86e-05	0.00014	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—CYP1A1—liver cancer	3.85e-05	0.00014	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—VEGFA—liver cancer	3.79e-05	0.000137	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—GOT2—liver cancer	3.76e-05	0.000136	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—PIK3CD—liver cancer	3.75e-05	0.000136	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—STAT3—liver cancer	3.75e-05	0.000136	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—PIK3CD—liver cancer	3.74e-05	0.000136	CbGpPWpGaD
Tolterodine—CHRM1—GPCR downstream signaling—PIK3CA—liver cancer	3.72e-05	0.000135	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—SERPINE1—liver cancer	3.71e-05	0.000135	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—PIK3CA—liver cancer	3.71e-05	0.000134	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—PIK3CD—liver cancer	3.71e-05	0.000134	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—SERPINE1—liver cancer	3.7e-05	0.000134	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—KRAS—liver cancer	3.67e-05	0.000133	CbGpPWpGaD
Tolterodine—CHRM2—GPCR downstream signaling—PIK3CA—liver cancer	3.67e-05	0.000133	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—SERPINE1—liver cancer	3.66e-05	0.000133	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—KRAS—liver cancer	3.66e-05	0.000133	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—KRAS—liver cancer	3.63e-05	0.000132	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—VEGFA—liver cancer	3.63e-05	0.000132	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—MTHFR—liver cancer	3.62e-05	0.000131	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—MTHFR—liver cancer	3.59e-05	0.00013	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—STAT3—liver cancer	3.59e-05	0.00013	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—PPARA—liver cancer	3.55e-05	0.000129	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—CYP2E1—liver cancer	3.54e-05	0.000128	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—PPARA—liver cancer	3.52e-05	0.000128	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—MYC—liver cancer	3.48e-05	0.000126	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—TGFB1—liver cancer	3.48e-05	0.000126	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	3.47e-05	0.000126	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—PIK3CA—liver cancer	3.38e-05	0.000122	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—PIK3CA—liver cancer	3.37e-05	0.000122	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—RAF1—liver cancer	3.35e-05	0.000122	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—RAF1—liver cancer	3.34e-05	0.000121	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—MYC—liver cancer	3.34e-05	0.000121	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—PIK3CA—liver cancer	3.33e-05	0.000121	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—TGFB1—liver cancer	3.33e-05	0.000121	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—PIK3CG—liver cancer	3.31e-05	0.00012	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—CYCS—liver cancer	3.31e-05	0.00012	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—RAF1—liver cancer	3.31e-05	0.00012	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—MTOR—liver cancer	3.27e-05	0.000119	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—PIK3CB—liver cancer	3.27e-05	0.000119	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—MTOR—liver cancer	3.26e-05	0.000118	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—PIK3CB—liver cancer	3.26e-05	0.000118	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—GGT1—liver cancer	3.25e-05	0.000118	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—GOT1—liver cancer	3.25e-05	0.000118	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—PIK3CB—liver cancer	3.23e-05	0.000117	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—MTOR—liver cancer	3.23e-05	0.000117	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—KRAS—liver cancer	3.22e-05	0.000117	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—PPARG—liver cancer	3.19e-05	0.000116	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	3.16e-05	0.000115	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—HRAS—liver cancer	3.12e-05	0.000113	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—HRAS—liver cancer	3.11e-05	0.000113	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—HRAS—liver cancer	3.08e-05	0.000112	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—KRAS—liver cancer	3.08e-05	0.000112	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—CDKN1B—liver cancer	3.07e-05	0.000111	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—CDKN1B—liver cancer	3.06e-05	0.000111	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—PIK3CG—liver cancer	3.04e-05	0.00011	CbGpPWpGaD
Tolterodine—CHRM1—GPCR downstream signaling—AKT1—liver cancer	3.04e-05	0.00011	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—CDKN1B—liver cancer	3.03e-05	0.00011	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—AKT1—liver cancer	3.03e-05	0.00011	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—PIK3CG—liver cancer	3.02e-05	0.000109	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—CASP3—liver cancer	3.01e-05	0.000109	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—IL2—liver cancer	3e-05	0.000109	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—CASP3—liver cancer	3e-05	0.000109	CbGpPWpGaD
Tolterodine—CHRM2—GPCR downstream signaling—AKT1—liver cancer	3e-05	0.000109	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—IL2—liver cancer	2.99e-05	0.000109	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—IL6—liver cancer	2.99e-05	0.000108	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—IL6—liver cancer	2.98e-05	0.000108	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—CASP3—liver cancer	2.97e-05	0.000108	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—IL2—liver cancer	2.97e-05	0.000108	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—PIK3CA—liver cancer	2.96e-05	0.000107	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—IL6—liver cancer	2.95e-05	0.000107	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—PPARG—liver cancer	2.94e-05	0.000107	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—CCND1—liver cancer	2.93e-05	0.000106	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—JUN—liver cancer	2.92e-05	0.000106	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—CCND1—liver cancer	2.92e-05	0.000106	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—GSTP1—liver cancer	2.92e-05	0.000106	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—JUN—liver cancer	2.91e-05	0.000106	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—PPARG—liver cancer	2.91e-05	0.000106	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—PIK3CD—liver cancer	2.91e-05	0.000106	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—CTNNB1—liver cancer	2.9e-05	0.000105	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—CCND1—liver cancer	2.89e-05	0.000105	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—CTNNB1—liver cancer	2.89e-05	0.000105	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—JUN—liver cancer	2.89e-05	0.000105	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—HMOX1—liver cancer	2.88e-05	0.000104	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—ALB—liver cancer	2.87e-05	0.000104	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—CTNNB1—liver cancer	2.86e-05	0.000104	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—TP53—liver cancer	2.86e-05	0.000104	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—MMP9—liver cancer	2.84e-05	0.000103	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—MMP9—liver cancer	2.83e-05	0.000103	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—CDKN1A—liver cancer	2.83e-05	0.000103	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—PIK3CA—liver cancer	2.83e-05	0.000103	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—CDKN1A—liver cancer	2.82e-05	0.000102	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—MMP9—liver cancer	2.81e-05	0.000102	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—CDKN1A—liver cancer	2.8e-05	0.000101	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—MAPK8—liver cancer	2.77e-05	0.0001	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—AKT1—liver cancer	2.76e-05	0.0001	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—MAPK8—liver cancer	2.76e-05	0.0001	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—AKT1—liver cancer	2.75e-05	9.98e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—TP53—liver cancer	2.74e-05	9.94e-05	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—HRAS—liver cancer	2.74e-05	9.93e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—MAPK8—liver cancer	2.73e-05	9.91e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—AKT1—liver cancer	2.72e-05	9.88e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—GSTM1—liver cancer	2.68e-05	9.72e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—PIK3CD—liver cancer	2.68e-05	9.71e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—PIK3CD—liver cancer	2.65e-05	9.62e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—ALB—liver cancer	2.64e-05	9.58e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—HRAS—liver cancer	2.62e-05	9.51e-05	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—IL6—liver cancer	2.62e-05	9.5e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—ALB—liver cancer	2.62e-05	9.5e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—VEGFA—liver cancer	2.55e-05	9.26e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—VEGFA—liver cancer	2.55e-05	9.24e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—CYP1A1—liver cancer	2.54e-05	9.22e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—PIK3CB—liver cancer	2.54e-05	9.2e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—STAT3—liver cancer	2.53e-05	9.17e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—VEGFA—liver cancer	2.52e-05	9.15e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—STAT3—liver cancer	2.52e-05	9.14e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—IL6—liver cancer	2.51e-05	9.1e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—STAT3—liver cancer	2.5e-05	9.06e-05	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—AKT1—liver cancer	2.42e-05	8.77e-05	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—PIK3CA—liver cancer	2.38e-05	8.63e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—MTHFR—liver cancer	2.37e-05	8.59e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—MYC—liver cancer	2.35e-05	8.52e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—TGFB1—liver cancer	2.34e-05	8.5e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—MYC—liver cancer	2.34e-05	8.5e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—TGFB1—liver cancer	2.34e-05	8.48e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—PIK3CB—liver cancer	2.33e-05	8.46e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—PPARA—liver cancer	2.32e-05	8.43e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—MYC—liver cancer	2.32e-05	8.41e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—AKT1—liver cancer	2.31e-05	8.4e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—TGFB1—liver cancer	2.31e-05	8.39e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—PIK3CB—liver cancer	2.31e-05	8.39e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—KRAS—liver cancer	2.17e-05	7.88e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—KRAS—liver cancer	2.16e-05	7.85e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—KRAS—liver cancer	2.14e-05	7.78e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—PIK3CA—liver cancer	1.99e-05	7.24e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—PIK3CG—liver cancer	1.99e-05	7.22e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—PIK3CA—liver cancer	1.99e-05	7.21e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—PIK3CA—liver cancer	1.97e-05	7.14e-05	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—AKT1—liver cancer	1.94e-05	7.05e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—TP53—liver cancer	1.93e-05	7e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—TP53—liver cancer	1.92e-05	6.98e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—PPARG—liver cancer	1.92e-05	6.97e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—TP53—liver cancer	1.9e-05	6.91e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—HRAS—liver cancer	1.85e-05	6.69e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—HRAS—liver cancer	1.84e-05	6.67e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—HRAS—liver cancer	1.82e-05	6.61e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—IL6—liver cancer	1.77e-05	6.41e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—IL6—liver cancer	1.76e-05	6.39e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—PIK3CD—liver cancer	1.75e-05	6.35e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—IL6—liver cancer	1.74e-05	6.33e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—ALB—liver cancer	1.73e-05	6.27e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—AKT1—liver cancer	1.63e-05	5.91e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—AKT1—liver cancer	1.62e-05	5.89e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—AKT1—liver cancer	1.61e-05	5.84e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—PIK3CA—liver cancer	1.55e-05	5.61e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—PIK3CB—liver cancer	1.52e-05	5.53e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—PIK3CA—liver cancer	1.42e-05	5.16e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—PIK3CA—liver cancer	1.41e-05	5.11e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—AKT1—liver cancer	1.26e-05	4.58e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—AKT1—liver cancer	1.16e-05	4.21e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—AKT1—liver cancer	1.15e-05	4.18e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—PIK3CA—liver cancer	9.29e-06	3.37e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—AKT1—liver cancer	7.59e-06	2.75e-05	CbGpPWpGaD
